Smartphone app for sticking to your lung medication routine
Part of Blood & lymphatic, Heart & circulation, Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether a smartphone app called FORTISKAP helps people stick to their oral medications for lung conditions like interstitial lung disease and pulmonary hypertension. If you join, you'll either use the app or receive usual care, and the goal is to see if the app improves medication routines and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years or older.
- You must have a diagnosis of interstitial lung disease (including sarcoidosis) or pulmonary hypertension.
- You must manage your oral medications yourself, without a caregiver's help.
- You need to be taking (or about to start) an oral medication for your lung condition.
- You must have a 6-minute walk test either done recently or planned soon.
- You need a smartphone that can install apps and be comfortable using it in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a home-based exercise program, guided by a smartphone app, can improve your daily life and heart function if you have pulmonary hypertension. You will use a wearable device to track your activity and receive remote support from a medical team.
This study tests whether a smartphone app and special pill bottle help people take their acid reflux medication more regularly over 90 days.
This trial tests whether a digital self-management program (using a smartphone or tablet) helps people with fibrotic interstitial lung disease better manage their symptoms and quality of life. If you have this lung condition and can use a mobile device, this study could offer you extra support at home.
This study tests if a smartphone app can help people with pulmonary arterial hypertension (PAH) stick to their inhaled iloprost treatment. It is for adults already on this treatment at a specific clinic in Brazil.
This study tests whether using a home breathing device, combined with artificial intelligence, can help monitor your lung condition between clinic visits. If it works, it might catch changes early and help you stay healthier.
This study tests a smartphone app that helps you learn or improve how to use your inhaler correctly. The app provides education and training to make sure you get the most from your medication.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.